Skip Nav Destination
Issues
A Phase IB Trial of the PI3K Inhibitor Alpelisib and Weekly Cisplatin in Patients with Solid Tumor Malignancies
Erica S. Tsang; Rahul R. Aggarwal; Mallika S. Dhawan; Emily K. Bergsland; Edwin A. Alvarez; Susan Calabrese; Romain Pacaud; Jose Garcia; Delaire Fattah; Scott Thomas; Jennifer Grabowsky; Mark M. Moasser; Pamela N. Munster
Evaluation of the DLL3-targeting Antibody–Drug Conjugate Rovalpituzumab Tesirine in Preclinical Models of Neuroblastoma
Kateryna Krytska; Colleen E. Casey; Jennifer Pogoriler; Daniel Martinez; Komal S. Rathi; Alvin Farrel; Esther R. Berko; Matthew Tsang; Renata R. Sano; Nathan Kendsersky; Stephen W. Erickson; Beverly A. Teicher; Kumiko Isse; Laura Saunders; Malcolm A. Smith; John M. Maris; Yael P. Mossé
Interrogation of T Cell–enriched Tumors Reveals Prognostic and Immunotherapeutic Implications of Polyamine Metabolism
R. Alex Harbison; Rajeev Pandey; Michael Considine; Robert D. Leone; Tracy Murray-Stewart; Rossin Erbe; Raj Mandal; Mark Burns; Robert A. Casero, Jr; Tanguy Seiwert; Carole Fakhry; Drew Pardoll; Elana Fertig; Jonathan D. Powell
Prospective Associations of Hemoglobin A1c and c-peptide with Risk of Diabetes-related Cancers in the Cancer Prevention Study-II Nutrition Cohort
Peter T. Campbell; Christina C. Newton; Eric J. Jacobs; Marjorie L. McCullough; Ying Wang; Erika Rees-Punia; Mark A. Guinter; Neil Murphy; Jill Koshiol; Ahmed N. Dehal; Thomas Rohan; Howard Strickler; Jessica Petrick; Marc Gunter; Xuehong Zhang; Katherine A. McGlynn; Michael Pollak; Alpa V. Patel; Susan M. Gapstur
Chemical, Molecular, and Single-nucleus Analysis Reveal Chondroitin Sulfate Proteoglycan Aberrancy in Fibrolamellar Carcinoma
Adam B. Francisco; Jine Li; Alaa R. Farghli; Matt Kanke; Bo Shui; Paul R. Munn; Jennifer K. Grenier; Paul D. Soloway; Zhangjie Wang; Lola M. Reid; Jian Liu; Praveen Sethupathy
Bcl-xL Inhibition Radiosensitizes PIK3CA/PTEN Wild-type Triple-negative Breast Cancers with Low Mcl-1 Expression
Andrea M. Pesch; Benjamin C. Chandler; Anna R. Michmerhuizen; Hannah M. Carter; Nicole H. Hirsh; Kari Wilder-Romans; Meilan Liu; Tanner Ward; Cassandra L. Ritter; Charles A. Nino; Kassidy M. Jungles; Lori J. Pierce; James M. Rae; Corey W. Speers
Potent Stimulation of the Androgen Receptor Instigates a Viral Mimicry Response in Prostate Cancer
Mohammadreza Alizadeh-Ghodsi; Katie L. Owen; Scott L. Townley; Damien Zanker; Samuel P.G. Rollin; Adrienne R. Hanson; Raj Shrestha; John Toubia; Tessa Gargett; Igor Chernukhin; Jennii Luu; Karla J. Cowley; Ashlee Clark; Jason S. Carroll; Kaylene J. Simpson; Jean M. Winter; Mitchell G. Lawrence; Lisa M. Butler; Gail P. Risbridger; Benjamin Thierry; Renea A. Taylor; Theresa E. Hickey; Belinda S. Parker; Wayne D. Tilley; Luke A. Selth
The Combination of Radiotherapy and Complement C3a Inhibition Potentiates Natural Killer cell Functions Against Pancreatic Cancer
Quaovi H. Sodji; Dhanya K. Nambiar; Vignesh Viswanathan; Rie von Eyben; Deana Colburg; Michael S. Binkley; Caiyun G. Li; Monica M. Olcina; Daniel T. Chang; Quynh-Thu Le; Amato J. Giaccia
Mixed Response to Cancer Immunotherapy is Driven by Intratumor Heterogeneity and Differential Interlesion Immune Infiltration
Takao Morinaga; Takashi Inozume; Masahito Kawazu; Youki Ueda; Nicolas Sax; Kazuo Yamashita; Shusuke Kawashima; Joji Nagasaki; Toshihide Ueno; Jason Lin; Yuuki Ohara; Takeshi Kuwata; Hiroki Yukami; Akihito Kawazoe; Kohei Shitara; Akiko Honobe-Tabuchi; Takehiro Ohnuma; Tatsuyoshi Kawamura; Yoshiyasu Umeda; Yu Kawahara; Yasuhiro Nakamura; Yukiko Kiniwa; Ayako Morita; Eiki Ichihara; Katsuyuki Kiura; Tomohiro Enokida; Makoto Tahara; Yoshinori Hasegawa; Hiroyuki Mano; Yutaka Suzuki; Hiroyoshi Nishikawa; Yosuke Togashi
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.